Literature DB >> 29496071

MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.

Heqing Wang1, Chun Yang2, Shengxiang Rao3, Yuan Ji4, Jing Han5, Ruofan Sheng6, Mengsu Zeng7.   

Abstract

PURPOSE: To investigate and compare the MR features between hepatocellular adenoma (HCA) subtypes in China, including preliminary observations on diffusion-weighted imaging (DWI).
METHODS: Thirty-six patients with 39 pathologically proven HCAs underwent gadopentetate dimeglumine enhanced MRI. The morphological and imaging features on T1, T2-weighted, dynamic-enhanced imaging and DWI were retrospectively evaluated and compared between four HCA subtypes, using Kruskal-Wallis test, Fisher's exact test and Dunn-Bonferroni post hoc test.
RESULTS: HCA frequently occurred in male (n = 19, 52.8%), lacked an association with oral contraceptives (n = 0), and had a relatively high incidence of coexistent Hepatitis B infection (n = 6, 16.7%). Signals on T1 and T2-weighted imaging, enhancement pattern and intensity, lesion heterogeneity, as well as accompanying findings including lesion steatosis, necrosis or cystic component, central scar, and pseudocapsule were different between HCA subtypes (P < .0001 to P = .019). Apparent diffusion coefficient (ADC) values among HCA subtypes were different as a whole (P = .029), within which β-catenin-mutated HCA had the lowest ADCs; but post hoc comparisons demonstrated no significant differences between groups (P = .066-1.000).
CONCLUSION: Both clinical and MR imaging presentation of HCA in China had some specific characteristics, and a good relationship existed between MR data and genotype-phenotype classification. Furthermore, ADC value may provide a potential indicator of malignant transformation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular adenoma; Liver; Magnetic resonance imaging

Mesh:

Substances:

Year:  2018        PMID: 29496071     DOI: 10.1016/j.ejrad.2018.01.023

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

2.  Malignant transformation of hepatic adenoma complicated by rupture and hemorrhage: An extremely rare clinical entity.

Authors:  Rishi Philip Mathew; Florin Manolea; Safwat Girgis; Vimal Patel; Gavin Low
Journal:  Intractable Rare Dis Res       Date:  2019-11

Review 3.  New insights in the management of Hepatocellular Adenoma.

Authors:  Anne J Klompenhouwer; Robert A de Man; Marco Dioguardi Burgio; Valerie Vilgrain; Jessica Zucman-Rossi; Jan N M Ijzermans
Journal:  Liver Int       Date:  2020-06-11       Impact factor: 5.828

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.